Inovio Pharmaceuticals (INO) Accumulated Expenses (2010 - 2019)
Inovio Pharmaceuticals (INO) reported Accumulated Expenses of $4.5 million for Q3 2019, down 38.8% from $7.35 million a year earlier and down 3.0% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Accumulated Expenses (2010 - 2019) Analysis & Trends
At the end of FY2018, Inovio Pharmaceuticals posted Accumulated Expenses of $5.67 million, down 34.1% from FY2017.
- Accumulated Expenses has a five-year compound annual growth rate of 31.4% (FY2013 to FY2018).
- By year, Accumulated Expenses came in at $8.61 million in FY2017 (+35.2%), $6.37 million in FY2016 (+144.9%), $2.6 million in FY2015 (+29.5%) and $2.01 million in FY2014 (+38.8%).
- The Q3 2019 figure ranks as the lowest quarterly Accumulated Expenses since Q1 2016.
- Year over year, Accumulated Expenses has now declined in each of the last five quarters, with an average decline of 3.6% over the last eight quarters.
- The high point for year-over-year Accumulated Expenses in five years was Q1 2016 (growth of 227.6%); the low point was Q2 2019 (a decline of 55.2%).
- Per Business Quant data, the three quarters before Q3 2019 came in at $4.64 million (Q2 2019), $7.16 million (Q1 2019) and $5.67 million (Q4 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Inovio Pharmaceuticals | 98.76 Mn | 98.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 4.50 Mn |
| Jun 30, 2019 | 4.64 Mn |
| Mar 31, 2019 | 7.16 Mn |
| Dec 31, 2018 | 5.67 Mn |
| Sep 30, 2018 | 7.35 Mn |
| Jun 30, 2018 | 10.36 Mn |
| Mar 31, 2018 | 8.43 Mn |
| Dec 31, 2017 | 8.61 Mn |
| Sep 30, 2017 | 7.92 Mn |
| Jun 30, 2017 | 7.19 Mn |
| Mar 31, 2017 | 5.91 Mn |
| Dec 31, 2016 | 6.37 Mn |
| Sep 30, 2016 | 7.22 Mn |
| Jun 30, 2016 | 5.01 Mn |
| Mar 31, 2016 | 4.15 Mn |
| Dec 31, 2015 | 2.60 Mn |
| Sep 30, 2015 | 2.94 Mn |
| Jun 30, 2015 | 2.55 Mn |
| Mar 31, 2015 | 1.27 Mn |
| Dec 31, 2014 | 2.01 Mn |
API Access
Inovio Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();